GlobalData on MSN5d
J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contractSamsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...
Hosted on MSN20d
Very Important Patients Don't Just Do Something, Stand There!Medlife Crisis Very Important Patients Don't Just Do Something, Stand There! Posted: February 11, 2025 | Last updated: February 11, 2025 What lessons can be learnt from treating Trump? Why is his ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's ...
MAIA Biotechnology, Inc., ("MAIA," the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the trial design for the expansion of its ...
MAIA recently announced an amended clinical supply agreement with Regeneron to include the expansion ... acceptance of our product candidates, (vi) the size and growth potential of the markets ...
1VT.F Viking Therapeutics, Inc.
sequenced with Regeneron’s immune checkpoint inhibitor (CPI) cemiplimab (Libtayo ®) in patients with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care therapy ...
A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results that could allow the company to seek regulatory approval for the one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback